Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Immunological Assays Correlated for Lupus Diagnosis

By LabMedica International staff writers
Posted on 29 Feb 2012
Two immunoassays have been used to detect autoantibodies to the ribosomal P proteins (Rib-P) which are a serologic marker for systemic lupus erythematosus (SLE). More...


Enzyme immunoassays and an indirect immunofluorescence test have been tested and compared in their ability to diagnose SLE and to see whether the results are interrelated.

Scientists at Dong-A University College of Medicine (Busan, Republic of Korea) collected serum samples from 91 SLE patients, 50 rheumatoid arthritis patients and 43 healthy subjects, between March 2009 and May 2010. A total of 184 samples were analyzed for anti-Rib-P antibodies using two immunoassays and an indirect immunofluorescence test (IIF) simultaneously. The IIF on HEp-2 cells was assayed using HEP-ANA test system (Medical & Biological Laboratories, MBL, Naka-ku, Japan) and anti-Rib-P antibodies by IIF were determined by the pattern with cytoplasmic and nucleolar staining.

Of 91 SLE patients, the positive rates of two immunoassays for anti-Rib-P antibodies were significantly higher than that of IIF. Eleven of 91 SLE patients showed simultaneous positivity in two immunoassays, but negativity in IIF. None of 93 control group subjects was positive for anti-Rib-P antibodies in two immunoassays and IIF. The two immunoassays used were the Quanta Lite Ribosome P enzyme-linked immunosorbent assay (ELISA) (Inova Diagnostics, San Diego, CA, USA) which uses synthetic ribosome P antigen and the EliA Rib-P (Phadia AB; Uppsala, Sweden) which uses human recombinant ribosomal P-proteins P0, P1, and P2.

The authors concluded that the sensitivity of immunofluorescence antibody tests (IFA) on HEp-2 cells is not optimal as a first-line screening test for detection of anti-Rib-P in SLE patients. Therefore, additional immunoassays are required to determine the presence of anti-Rib-P antibodies. The high titer of anti-Rib-P antibodies determined using immunoassays could also be demonstrated by IIF on HEp-2 cells. The discrepancy between immunoassays and IIF on HEp-2 cells for detection of anti-Rib-P antibodies may be explained by their titer. The study was published on March 15, 2012, in the journal Clinica Chimica Acta.

Related Links:
Dong-A University College of Medicine
Medical & Biological Laboratories
Inova Diagnostics



Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Human Estradiol Assay
Human Estradiol CLIA Kit
Homocysteine Quality Control
Liquichek Homocysteine Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.